Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells

Zuyao Ni, Wei Lou, Eddy S. Leman, Allen C Gao

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

Overexpression of interleukin 6, a downstream target of the GEX2 homeobox gene, has been linked to the progression of prostate cancer. The Janus kinase-signal transducers and activators of transcription signaling pathway transmits interleukin 6-mediated signals from cell surface receptors to the target genes in the nucleus and is critical in mediating cellular growth and differentiation. We demonstrate the cells derived from both rat and human prostate cancers have constitutively activated Stat3, with Stat3 activation being correlated with malignant potential. Blockade of activated Stat3 by ectopic expression of a dominant-negative Stat3 in human prostate cancer cells significantly suppresses their growth in vitro and their tumorigenicity in vivo. Furthermore, the Janus kinase inhibitor, tyrphostin AG490, inhibited the constitutive activation of Stat3 and suppressed the growth of human prostate cancer cells. These results indicate that activation of Stat3 signaling is essential in the progression of prostate cancer cells and suggest that targeting Stat3 signaling may yield a potential therapeutic intervention for prostate cancer.

Original languageEnglish (US)
Pages (from-to)1225-1228
Number of pages4
JournalCancer Research
Volume60
Issue number5
StatePublished - Mar 1 2000
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Growth
Janus Kinases
Interleukin-6
Tyrphostins
Homeobox Genes
Cell Surface Receptors
Transducers
Genes
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. / Ni, Zuyao; Lou, Wei; Leman, Eddy S.; Gao, Allen C.

In: Cancer Research, Vol. 60, No. 5, 01.03.2000, p. 1225-1228.

Research output: Contribution to journalArticle

@article{acc7be67ce5540d783aca5a4e3d4177e,
title = "Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells",
abstract = "Overexpression of interleukin 6, a downstream target of the GEX2 homeobox gene, has been linked to the progression of prostate cancer. The Janus kinase-signal transducers and activators of transcription signaling pathway transmits interleukin 6-mediated signals from cell surface receptors to the target genes in the nucleus and is critical in mediating cellular growth and differentiation. We demonstrate the cells derived from both rat and human prostate cancers have constitutively activated Stat3, with Stat3 activation being correlated with malignant potential. Blockade of activated Stat3 by ectopic expression of a dominant-negative Stat3 in human prostate cancer cells significantly suppresses their growth in vitro and their tumorigenicity in vivo. Furthermore, the Janus kinase inhibitor, tyrphostin AG490, inhibited the constitutive activation of Stat3 and suppressed the growth of human prostate cancer cells. These results indicate that activation of Stat3 signaling is essential in the progression of prostate cancer cells and suggest that targeting Stat3 signaling may yield a potential therapeutic intervention for prostate cancer.",
author = "Zuyao Ni and Wei Lou and Leman, {Eddy S.} and Gao, {Allen C}",
year = "2000",
month = "3",
day = "1",
language = "English (US)",
volume = "60",
pages = "1225--1228",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells

AU - Ni, Zuyao

AU - Lou, Wei

AU - Leman, Eddy S.

AU - Gao, Allen C

PY - 2000/3/1

Y1 - 2000/3/1

N2 - Overexpression of interleukin 6, a downstream target of the GEX2 homeobox gene, has been linked to the progression of prostate cancer. The Janus kinase-signal transducers and activators of transcription signaling pathway transmits interleukin 6-mediated signals from cell surface receptors to the target genes in the nucleus and is critical in mediating cellular growth and differentiation. We demonstrate the cells derived from both rat and human prostate cancers have constitutively activated Stat3, with Stat3 activation being correlated with malignant potential. Blockade of activated Stat3 by ectopic expression of a dominant-negative Stat3 in human prostate cancer cells significantly suppresses their growth in vitro and their tumorigenicity in vivo. Furthermore, the Janus kinase inhibitor, tyrphostin AG490, inhibited the constitutive activation of Stat3 and suppressed the growth of human prostate cancer cells. These results indicate that activation of Stat3 signaling is essential in the progression of prostate cancer cells and suggest that targeting Stat3 signaling may yield a potential therapeutic intervention for prostate cancer.

AB - Overexpression of interleukin 6, a downstream target of the GEX2 homeobox gene, has been linked to the progression of prostate cancer. The Janus kinase-signal transducers and activators of transcription signaling pathway transmits interleukin 6-mediated signals from cell surface receptors to the target genes in the nucleus and is critical in mediating cellular growth and differentiation. We demonstrate the cells derived from both rat and human prostate cancers have constitutively activated Stat3, with Stat3 activation being correlated with malignant potential. Blockade of activated Stat3 by ectopic expression of a dominant-negative Stat3 in human prostate cancer cells significantly suppresses their growth in vitro and their tumorigenicity in vivo. Furthermore, the Janus kinase inhibitor, tyrphostin AG490, inhibited the constitutive activation of Stat3 and suppressed the growth of human prostate cancer cells. These results indicate that activation of Stat3 signaling is essential in the progression of prostate cancer cells and suggest that targeting Stat3 signaling may yield a potential therapeutic intervention for prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0034163461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034163461&partnerID=8YFLogxK

M3 - Article

C2 - 10728680

AN - SCOPUS:0034163461

VL - 60

SP - 1225

EP - 1228

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -